Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06636123 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revisedv6
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 30, 2025 to Feb 18, 2025
    • Site details revised
    v5
  3. Start date: Dec 30, 2024 to Mar 30, 2025v4
  4. Start date: Nov 13, 2024 to Dec 30, 2024
    • Primary completion date: Mar 31, 2027 to Apr 30, 2027
    • Study completion date: Sep 30, 2031 to Oct 31, 2031
    v3
  5. Primary completion date: Feb 28, 2027 to Mar 31, 2027
    • Study completion date: Aug 31, 2031 to Sep 30, 2031
    • Start date: Oct 31, 2024 to Nov 13, 2024
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this clinical trial is to determine if GZ17-6.02 delays progression of castration-resistant prostate cancer.
Trial Details
NCT Number NCT06636123
Lead Sponsor Virginia Commonwealth University
Conditions
(from sponsor)		 Castration-resistant Prostate Cancer
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov